Warning! GuruFocus detected
1 Severe warning sign
with ACLX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Arcellx Inc
NAICS : 325412
SIC : 2834
ISIN : US03940C1009
Description
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.86 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.55 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 7.02 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | -1.1 | |||||
| 3-Year FCF Growth Rate | -0.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -11.24 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 37.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.25 | |||||
| 9-Day RSI | 41.23 | |||||
| 14-Day RSI | 41.78 | |||||
| 3-1 Month Momentum % | -2.1 | |||||
| 6-1 Month Momentum % | -14.71 | |||||
| 12-1 Month Momentum % | 16.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.78 | |||||
| Quick Ratio | 4.78 | |||||
| Cash Ratio | 4.68 | |||||
| Days Sales Outstanding | 106.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.4 | |||||
| Shareholder Yield % | 0.83 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -127.46 | |||||
| Net Margin % | -99.46 | |||||
| FCF Margin % | -89.78 | |||||
| ROE % | -22.3 | |||||
| ROA % | -14.07 | |||||
| ROIC % | -54.76 | |||||
| 3-Year ROIIC % | -42.76 | |||||
| ROC (Joel Greenblatt) % | -148.52 | |||||
| ROCE % | -16.1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 28.4 | |||||
| PB Ratio | 6.84 | |||||
| Price-to-Tangible-Book | 6.84 | |||||
| EV-to-EBIT | -26.19 | |||||
| EV-to-Forward-EBIT | -14.28 | |||||
| EV-to-EBITDA | -27.56 | |||||
| EV-to-Forward-EBITDA | -16.11 | |||||
| EV-to-Revenue | 25.3 | |||||
| EV-to-Forward-Revenue | 32.11 | |||||
| EV-to-FCF | -27.71 | |||||
| Price-to-Net-Current-Asset-Value | 9.08 | |||||
| Price-to-Net-Cash | 9.41 | |||||
| Earnings Yield (Greenblatt) % | -3.82 | |||||
| FCF Yield % | -3.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arcellx Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 107.936 | ||
| EPS (TTM) ($) | -2 | ||
| Beta | 0.44 | ||
| 3-Year Sharpe Ratio | 1.02 | ||
| 3-Year Sortino Ratio | 2.12 | ||
| Volatility % | 45.64 | ||
| 14-Day RSI | 41.78 | ||
| 14-Day ATR ($) | 4.950799 | ||
| 20-Day SMA ($) | 66.6565 | ||
| 12-1 Month Momentum % | 16.81 | ||
| 52-Week Range ($) | 47.88 - 107.3699 | ||
| Shares Outstanding (Mil) | 54.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arcellx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arcellx Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arcellx Inc Frequently Asked Questions
What is Arcellx Inc(ACLX)'s stock price today?
The current price of ACLX is $57.28. The 52 week high of ACLX is $107.37 and 52 week low is $47.88.
When is next earnings date of Arcellx Inc(ACLX)?
The next earnings date of Arcellx Inc(ACLX) is 2025-05-09 Est..
Does Arcellx Inc(ACLX) pay dividends? If so, how much?
Arcellx Inc(ACLX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers